Market Access

Four Key Questions About Payer/Provider Strategies

PM360 asked experts in engaging with payers and providers to address key issues the ...

Will UnitedHealthcare’s New Rebate Strategy Put Pharma at Risk?

Earlier this month, UnitedHealthcare, a UnitedHealth Group company, announced it will expand pharmacy discounts ...

Who Needs to Care about Value Frameworks?

Public scrutiny on healthcare costs, particularly drug costs, has been mounting over the past ...

Personalized Medicine is the Natural Evolution of Healthcare

Personalized Medicine is the natural progression of medicine and science. If we are interested ...

Next-Generation Forecasting Must Account for Payer Controls

The market access landscape for pharmaceutical products has shifted as payers struggle to control ...

Accelerating Appropriate Access to Therapy with Centralized Patient Support

Rising patient financial obligations have led to increased patient consumerism, changing the game for ...

Are We Reaching the End of the Line for PBM Exclusion Lists?

In the rapidly evolving U.S. healthcare landscape, the pharmacy benefit manager (PBM) exclusion lists ...

Common Pitfalls to Avoid to Ensure a Successful Product Launch

After spending millions on R&D just to get a product to market—and millions more ...